RecruitingNCT06962995

Multi-Cancer Detection Observational Cohort Study

Sponsor

Mayo Clinic

Enrollment

500 participants

Start Date

May 7, 2025

Study Type

OBSERVATIONAL

Conditions

Cancer

Summary

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Blood Sample and Surveys for people with cancer. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBlood Sample

Up to 60 mL (about 4-5 Tbsp) of blood may be collected for an initial blood draw and up to 30 mL (about 2-3 Tbsp) may be collected for a second blood draw, 25-45 days after first blood draw. The research blood will be collected at the time of a clinical blood draw, if possible.

OTHERSurveys

Participants will complete surveys related to attitudes and beliefs around Multi-Cancer Detection testing.